CHANISE FRANDSEN: Open Payments
NPI 1083211759 · WEBSTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$16,958 in 177 payments from 25 companies in 2025. Trend: 2023 $2,586 · 2024 $7,552 · 2025 $16,958
Speaker / faculty: $11,390Food & beverage: $4,256Travel & lodging: $1,214Education: $98
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 28 | $10,396 |
| AstraZeneca Pharmaceuticals LP | 25 | $3,689 |
| GENZYME CORPORATION | 26 | $537 |
| Novartis Pharmaceuticals Corporation | 23 | $437 |
| ARS Pharmaceuticals Operations, Inc. | 11 | $230 |
| GlaxoSmithKline, LLC. | 13 | $230 |
| Organon LLC | 6 | $198 |
| Grifols USA, LLC | 7 | $168 |
| Incyte Corporation | 8 | $162 |
| Ionis Pharmaceuticals, Inc. | 3 | $140 |
Products named: DUPIXENT, TEZSPIRE, NEFFY, NUCALA, AIRSUPRA, OPZELURA, FASENRA, DAWNZERA.
Industry payments across TX — which companies pay providers there.
